House leaders on Wednesday blasted the CEO of EpiPen’s manufacturer, which raised the price of the allergy drug by 400 percent, saying that the sharp price increase could endanger the lives of their constituents.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.